Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute for Cardiovascular Diseases Dedinje

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Institute for Cardiovascular Diseases “Dedinje” (IKVBD), located in Belgrade, Serbia, is the largest specialized center for the treatment of acquired cardiovascular diseases in Southeastern Europe. It is a highly advanced, tertiary-care institution that combines clinical excellence with a strong focus on scientific research, making it a key healthcare and research hub in the region. () IKVBD offers a comprehensive range of cardiovascular services through its multiple clinical units, including clinical cardiology, interventional cardiology, cardiac and vascular surgery, anesthesiology, and intensive care. The institute is equipped with state-of-the-art infrastructure, including hybrid operating rooms and advanced simulation laboratories such as the CardioView3D Lab, which supports complex surgical planning and physician training

Source: Trial-derived.
36Total Trials
Source: Trial-derived.
10Recruiting Trials
Source: Trial-derived.
15Active Trials
Source: Trial-derived.
16Completed Trials
Source: Trial-derived.
47Unique Conditions
Source: Trial-derived.
50Unique Sponsors

Conditions

Source: Trial-derived. Coronary Artery Disease (8)Source: Trial-derived. Atrial Fibrillation (3)Source: Trial-derived. Carotid Artery Diseases (2)Source: Trial-derived. Heart Diseases (2)Source: Trial-derived. Mitral Valve Regurgitation (2)Source: Trial-derived. Myocardial Infarction (2)Source: Trial-derived. Pulmonary Arterial Hypertension (2)Source: Trial-derived. Stroke (2)

Sponsors

Source: Trial-derived. Boehringer Ingelheim (4)Source: Trial-derived. Weill Medical College of Cornell University (4)Source: Trial-derived. Canadian Institutes of Health Research (CIHR) (3)Source: Trial-derived. Institute for Cardiovascular Diseases Dedinje (3)Source: Trial-derived. Berlin Heals GmbH (2)Source: Trial-derived. Bristol-Myers Squibb (2)Source: Trial-derived. Clinical Centre of Serbia (2)Source: Trial-derived. Janssen Research & Development, LLC (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot